ESC 365 - The predictive value of routine troponin measurements in patients treated with immune checkpoint inhibitors

HFA Premium Access

The predictive value of routine troponin measurements in patients treated with immune checkpoint inhibitors

Session: How to improve prognosis in cardio-oncology

Topic: Cardio-Oncology

Speaker: Doctor M. Laufer-Perl (Tel Aviv, IL)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Doctor Michal Laufer-Perl

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

0 follower

4 more presentations in this session

Cardiotoxicity in multiple myeloma patients in Hong Kong: a single-centre experience in the past decade

Speaker: Doctor M. Ho (Hong Kong, HK)

Inherited cardiovascular disease mindset at cardio-oncology screening

Speaker: Doctor R. Lorca (Oviedo, ES)

Soluble guanylate cyclase activator vericiguat prevents anthracycline-mediated cardiotoxicity and sarcopenia through NO-sGC-cGMP-NLRP3 pathway

Speaker: Doctor N. Maurea (Naples, IT)

Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study

Speaker: Doctor A. Abiodun (London, GB)

Access the full session

How to improve prognosis in cardio-oncology

Speakers: Doctor M. Laufer-Perl, Doctor M. Ho, Doctor R. Lorca, Doctor N. Maurea, Doctor A. Abiodun

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources